UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061375
Receipt number R000069941
Scientific Title A Prospective Comparative Study of Total Underwater Colonoscopy and CO2 Insufflation by Tandem Colonoscopy
Date of disclosure of the study information 2026/05/01
Last modified on 2026/04/26 12:30:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study comparing total underwater colonoscopy and CO2 insufflation colonoscopy

Acronym

Underwater vs CO2 Colonoscopy Study

Scientific Title

A Prospective Comparative Study of Total Underwater Colonoscopy and CO2 Insufflation by Tandem Colonoscopy

Scientific Title:Acronym

TUC-CO2 Study

Region

Japan


Condition

Condition

Colorectal tumor

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Total underwater colonoscopy (TUC) is a technique in which insertion is performed using water-assisted colonoscopy (WAC), and during withdrawal, the lumen is filled with water without gas insufflation for observation. By achieving moderate luminal distension and improving visibility through the optical properties of water, TUC is theoretically expected to reduce the polyp miss rate. In this study, we compare TUC with CO2 insufflation during colonoscope withdrawal to evaluate withdrawal time, polyp miss rate, and the characteristics of polyps missed by each method. In addition, patient pain scores are assessed to comprehensively examine the usefulness and safety of TUC.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

polyp miss rate and adenoma miss rate

Key secondary outcomes

polyp detection rate and adenoma detection rate, withdrawal time, procedural pain assessment, sedative dosage


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

First perform withdrawal under water immersion, then perform withdrawal using CO2 insufflation. The intervention period is defined as the time from obtaining informed consent to two weeks after the examination and treatment.

Interventions/Control_2

First perform withdrawal using CO2 insufflation, followed by withdrawal under water immersion. The intervention period is defined as the time from obtaining informed consent to two weeks after the examination and treatment.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients undergoing inpatient treatment for colorectal tumors
2. Patients aged 18 years or older at the time of obtaining informed consent
3. No restriction on sex
4. Patients who have received sufficient explanation regarding participation in this study and have provided written informed consent of their own free will with adequate understanding

Key exclusion criteria

1. Patients with a history of colorectal surgery(excluding appendectomy)
2. Patients with inflammatory bowel disease
3. Patients with polyposis
4. Patients with heart failure(NYHA class III or IV)
5. Patients with severe hepatic dysfunction (Child Pugh class B or C)
6. Patients with chronic renal failure undergoing hemodialysis or peritoneal dialysis
7. Pregnant patients
8. Patients deemed ineligible for this study by the investigator

Target sample size

50


Research contact person

Name of lead principal investigator

1st name koichi
Middle name
Last name Hamabe

Organization

Yamaguchi University

Division name

Department of Gastroenterology and Hepatology

Zip code

755-8505

Address

1-1-1 Minamikogushi, Ube, Yamaguchi, Japan

TEL

0836-22-2241

Email

khamabe@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name koichi
Middle name
Last name Hamabe

Organization

Yamaguchi University

Division name

Department of Gastroenterology and Hepatology

Zip code

755-8505

Address

1-1-1 Minamikogushi, Ube, Yamaguchi, Japan

TEL

0836-22-2241

Homepage URL


Email

khamabe@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Center, Yamaguchi University Hospital

Address

1-1-1 Minamikogushi, Ube, Yamaguchi, Japan

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 03 Month 10 Day

Date of IRB


Anticipated trial start date

2026 Year 05 Month 10 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 26 Day

Last modified on

2026 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069941